Halyard Health (HYH) Tops Q2 EPS by 14c

Halyard Health (NYSE: HYH) reported Q2 EPS of $0.51, $0.14 better than the analyst estimate of $0.37. Revenue for the quarter came in at $399 million versus the consensus estimate of $399.7 million.

GUIDANCE:

Halyard Health sees FY2017 EPS of $1.85-$2.05, versus the consensus of $1.85.

For earnings history and earnings-related data on Halyard Health (HYH) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• InspireMD (NSPR) Tops Q2 EPS by 1c
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance